Market Overview

Canaccord Genuity Maintains Hold on Cardiome Pharma Corporation, Raises PT to $0.40

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for CRME

DateFirmActionFromTo
Jun 2016H.C. WainwrightInitiates Coverage onBuy
May 2016Mackie ResearchUpgradesHoldSpeculative Buy
Mar 2016Brean CapitalMaintainsBuy

View More Analyst Ratings for CRME
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings

 

Related Articles (CRME)